Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Implementing Co-innovation to Develop an Accessible, Web-Based Exercise Program for People with Multiple Sclerosis.
Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis.
Optic Neuritis in Temporal Association With Cosmetic Hyaluronic Acid Injection: A Case Requiring Differentiation From Ischemic Optic Neuropathy.
Exosomes: A new frontier in the treatment of neurological diseases.
Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis.
The Multiple Sclerosis Severity Allele rs10191329 and Cognitive Function: A UK Biobank Study.
Measurement of the absolute value of the optical birefringence of myelin in primate brain tissue.
Microbiota and mycobiota in chronic inflammatory demyelinating polyneuropathy: clinical and pathophysiological correlations.
Chimeric antigen receptor-based cell therapies for neuroimmune disorders: Therapeutic advances and structured standard treatment models.
Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study.
Exploring the Feasibility and Patient Acceptance of RAGT for Overground Ambulation in Adults With Guillain-Barré Syndrome: A Scoping Review.
Acute Encephalopathy in Multiple Sclerosis With Renal Failure: Synergistic Neurotoxicity of Baclofen and Meropenem.
How Epstein-Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons.
Quantitative determination of longitudinal CNS cholesterol loss during myelin damage and repair.
Unmasking Probable Bickerstaff Brainstem Encephalitis in the Absence of Radiological and Cerebrospinal Fluid Clues.
Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis.
Neuroprotective effects of glucotropaeolin as the major glucosinolate of cress seed on cuprizone-induced mouse model of multiple sclerosis.
Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice.
Physical activity and exercise participation-Impact on motor and non-motor outcomes in early-stage Parkinson disease: A cross-sectional study.
Diagnostic Delay in Multiple Sclerosis in China: A Nationwide Cross-Sectional Study.
Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study.
PIM1-Induced Drp1 Phosphorylation Disrupts Microglial Mitophagy and Aggravates Neuroinflammation.
A blood transcriptomic signature anchored to central nervous system pathology enables noninvasive detection of multiple sclerosis.
Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.
Home-based exoskeleton use to improve quality of life in patients with multiple sclerosis: study protocol of a multicentre, randomised, cross-over trial.

Pages